Company intelligence / Profile preview

Nexture Bio

Woodland, California, United Statesnexturebio.com ↗

Ownership: Private
Development stage: Commercial

Overview

Nexture Bio develops animal-origin-free, plant-based microcarriers and scaffolds that enable scalable adherent cell culture processes. Their technologies support the creation of structured cultivated meat products resembling whole cuts. In January 2025, they acquired Matrix Food Technologies to expand their portfolio. They have launched commercial products and custom R&D services supporting both food/life science sectors.

Modalities: MicrocarrierScaffold
Industry: Non-Drug Biotech

Partnerships

Notable partnerships include participation in George Washington Carver Science Park for space-related food tech R&D.

Beyond the preview

Go deeper on Nexture Bio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nexture Bio.

Explore the full profile